AI as a Tool, Not the Answer: A Practical View for Life Sciences Commercial Teams

Artificial intelligence has moved quickly from experimentation to practical use across life sciences. Commercial teams are now exploring AI for market landscaping, segmentation, targeting, messaging, launch planning, content development, omnichannel orchestration, field enablement, and performance analytics. The opportunity is real: AI can help teams process more information, recognize patterns faster, and scale activities that previously required significant manual effort.

But the most important point is also the easiest to miss: AI is a tool, not the answer. In life sciences commercial work, the answer still depends on strategy, context, compliance, clinical nuance, customer understanding, and human accountability. AI can accelerate the path to better decisions, but it should not be mistaken for the decision itself.

Where AI Can Help Commercial Teams

Commercial life sciences projects often involve multiple data sources, complex stakeholder dynamics, and time-sensitive decisions. AI can be especially useful when the work requires synthesis, pattern recognition, scenario development, or repeatable execution support. For example, AI can help summarize market research, identify themes in healthcare professional feedback, compare engagement patterns across segments, draft first-pass messaging frameworks, or create structured hypotheses for a brand team to evaluate.

  • Insight generation: AI can review large volumes of inputs—such as market research, call notes, advisory board themes, claims trends, or omnichannel engagement data—and organize them into themes for human review.
  • Segmentation and targeting support: AI can help explore patterns across accounts, healthcare professionals, or patient populations, but business teams must validate whether those patterns are meaningful, ethical, compliant, and actionable.
  • Launch planning: AI can support scenario planning, risk identification, and workstream organization, helping teams ask better questions earlier in the process.
  • Content and message development: AI can create first drafts, alternative language, or audience-specific variations, but medical, legal, regulatory, brand, and customer context must guide final decisions.
  • Field enablement: AI can help summarize account insights, suggest preparation points, or organize relevant resources, while the field team remains responsible for judgment, relationship management, and compliant engagement.

The Discipline: AI Supports Judgment

The right question is not, “What did AI say?” The better question is, “How does this AI output help us think more clearly?” That distinction matters. In a regulated industry, commercial teams cannot outsource accountability to a model. AI may produce a useful synthesis, but teams must challenge the assumptions, inspect the data sources, test the conclusions, and determine whether the recommendation fits the customer, therapy area, market access environment, patient need, and compliance requirements.

In practice, this means treating AI outputs as inputs to a disciplined decision process. A strong commercial team uses AI to expand its view, pressure-test its thinking, and reduce manual effort. It does not use AI to bypass strategic debate, evidence review, or governance.

Five Principles for Using AI Effectively

  1. Start with the business question. AI is most useful when the team is clear about the decision it needs to make, the evidence required, and the constraints that matter.
  2. Know the data behind the output. Teams should understand what data was used, what was excluded, and where bias or gaps may exist.
  3. Keep humans in the loop. AI can recommend, summarize, and draft, but accountable people must review, approve, and own the final action.
  4. Design for compliance from the beginning. Commercial, medical, legal, regulatory, privacy, and information security considerations should be built into the workflow, not added after the fact.
  5. Measure value, not novelty. The goal is not to use AI because it is new; the goal is to improve speed, quality, consistency, customer relevance, or decision confidence.

AI in Practice: Patient Journey Analytics

One practical example is the use of AI to support patient journey analytics for a candidate drug. Ensuring that targeted patients with the relevant disease states are accurately identified begins with understanding the patient journey: how patients are diagnosed, what regimens they receive, how long they remain on therapy, how cycles of treatment are sequenced, and when they progress to the next line of therapy. This is a complex commercial analytics problem because the signal is distributed across time, therapies, claims activity, and real-world treatment behavior.

  • Open and closed claims each play a different role. Many organizations use both open and closed claims, and understanding what each contains is critical to success. Open claims may include a larger patient population than closed claims, but they often have gaps that make longitudinal patient journey analysis more difficult. Closed claims, by contrast, can support a cleaner view of continuously enrolled patients over a defined window, such as three years, which can be extremely useful for understanding treatment journeys but may also restrict population counts.
  • Closed claims can provide training context for open claims. A continuously closed patient population can help teams define regimen logic, treatment sequences, timing, cycle counts, and progression patterns. That curated view can then become a reference point for interpreting open claims, where missing data and incomplete histories may obscure the true journey.
  • AI can help identify where the data is incomplete, but the rules must come from the commercial analytics team. AI can compare patterns observed in closed claims or other training data against the more fragmented open claims environment. It can help flag likely gaps, suggest where the journey may be under-observed, and surface areas where additional validation is needed. More importantly, the commercial analytics team must define the rules for regimens, drug holidays, progression, adherence, and expected discontinuation, including situations where patients may be cured, in remission, lost to follow-up, or deceased. Those definitions are not technical details; they materially change the patient journey and progression rates.

The value of AI in this example is not that it produces a final answer about the patient journey. Its value is that it helps analysts work through the many parameters that can significantly change the journey and alter patient progression rates. AI can help test alternative assumptions, compare outputs across different rule sets, and identify where the interpretation of open claims diverges from patterns seen in closed claims or training data. The commercial team must then compare those results to training data, industry biosimilar experience, clinical context, and common sense. AI helps create a sharper starting point, but the final interpretation still requires analytical discipline and human accountability.

The Takeaway

AI will continue to become more capable, more accessible, and more embedded in life sciences commercial work. The organizations that gain the most value will not be the ones that treat AI as a magic answer. They will be the ones that treat it as a powerful tool within a thoughtful operating model that combines data, technology, governance, and human expertise. Used well, AI can help commercial teams move faster, ask better questions, and make more confident decisions. But the responsibility for those decisions remains human.

How RCM Life Sciences Can Help

RCM Life Sciences helps organizations apply AI, data, and digital technologies to complex Life Sciences challenges while maintaining the strategy, governance, and human oversight needed to support effective decision-making. Our team brings practical experience across data and analytics, digital transformation, project management, regulatory compliance, and technology initiatives.

From evaluating opportunities for AI and analytics to supporting implementation and ongoing execution, RCM Life Sciences helps teams connect technology with the business context, data, processes, and expertise needed to put it to work effectively. Contact our team to learn more.